Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect

221Citations
Citations of this article
99Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Celiac disease is probably the best-understood immune-related disorder. The disease presents in the small intestine and results from the interplay between multiple genes and gluten, the triggering environmental factor. Although HLA class II genes explain 40% of the heritable risk, non-HLA genes accounting for most of the familial clustering have not yet been identified. Here we report significant and replicable association (P = 2.1 × 10-6) to a common variant located in intron 28 of the gene myosin IXB (MYO9B), which encodes an unconventional myosin molecule that has a role in actin remodeling of epithelial enterocytes. Individuals homozygous with respect to the at-risk allele have a 2.3-times higher risk of celiac disease (P = 1.55 × 10-5). This result is suggestive of a primary impairment of the intestinal barrier in the etiology of celiac disease, which may explain why immunogenic gluten peptides are able to pass through the epithelial barrier. © 2005 Nature Publishing Group.

Cite

CITATION STYLE

APA

Monsuur, A. J., Bakker, P. I. W. D., Alizadeh, B. Z., Zhernakova, A., Bevova, M. R., Strengman, E., … Wijmenga, C. (2005). Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nature Genetics, 37(12), 1341–1344. https://doi.org/10.1038/ng1680

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free